Mission Produce: A Priced-In Merger with the Proof Still to Come

Mission Produce reported a quarter that looked contradictory, and the contradiction is the story. Revenue climbed 26% to $450 million, adjusted earnings came in below what analysts expected, and the stock rose about 6% in after-hours trading. For a reader looking at the headline numbers, that sequence does not compute. It makes sense only once you see what the company has become over the past four months: no longer a pure avocado price play, but a far larger, debt-funded platform assembled by buying rival Calavo Growers.

Start with what actually happened in the fiscal third quarter, which ran through late July. Mission sold about 253 million pounds of avocados, up 38% year over year, and revenue rose 26% to $450 million. On the surface that is a blowout. But the growth was largely bought, not earned: most of the extra volume came from Calavo, whose acquisition closed on May 28 and whose books rolled into Mission's results for the last part of the quarter. The pressure on the existing business shows up underneath. Average avocado selling prices fell 9% year over year on a larger industry supply, and reported GAAP net income swung to a $6.5 million loss, driven by $12.6 million in one-time transaction and integration costs.

That is why adjusted EPS ticked down to $0.18 from $0.26 a year earlier, a shade below the roughly $0.20 consensus, even as the top line surged. The earnings "miss" is integration noise plus a soft avocado price, not evidence that the combined company is worth less. Investors chose to look through it, and they had a metric to hang that on: adjusted EBITDA of $32.4 million came in above the top end of the $28 million-to-$32 million guidance range.

This is the turning point of the trade, so it is worth being precise about what the purchase actually bought. Calavo brought a second- and third-largest avocado footprint, packing capacity, and a value-added prepared-foods business — guacamole, salsas, fresh-cut product and private-label work — plus a blueberries line that Mission did not have. The strategic logic is straightforward: a commodity marketer of Hass avocados, whose revenue and margins swing with the world price of a fruit, gets a slice of higher-margin processed product and more sourcing security. Management raised its estimate of annualized cost synergies from at least $25 million to more than $30 million.

The stock's reaction says the market already sees that as a transformation rather than a one-off. Mission traded around $9.68 in early June, before the deal closed, and near $12.87 heading into this report — a roughly 30% re-rating over the summer. On that price the company carries about $1.1 billion in market value and roughly $1.2 billion in enterprise value. The trailing multiples look rich — near 19 times trailing EBITDA and about 50 times trailing earnings — but those figures are flattered and distorted at once: trailing EBITDA is depressed by several weak avocado-price quarters, and the earnings multiple is inflated by the one-time integration charges. Neither cleanly tells you whether the current price is fair.

What tells you more is the guidance for the next quarter. Mission guided fiscal fourth-quarter adjusted EBITDA to $52 million to $55 million — a sharp step-up from the $32.4 million just reported. That embeds a full quarter of Calavo, the seasonal sale of a larger Peru crop, and the early synergy savings. Add the >$30 million annualized synergy target and you have the whole bull case in one number: the merger is supposed to lift the recurring earnings floor high enough to make today's multiple look reasonable, not rich.

Here is the honest tension, and it is why this reads as a wait-and-verify rather than a buy-the-dip or a pay-up. The re-rating has already happened; the proof has not. Two risks sit on either side of the same lever. On one side, avocado prices are trending down, and Mission's own farming segment showed the strain — its adjusted EBITDA fell to $7.6 million from $12.1 million a year earlier as prices dropped. If the price cycle keeps turning, it can eat the synergy gains faster than they arrive, because this is still fundamentally an avocado company that happens to own a prepared-foods sidecar. On the other side, the balance sheet now carries the merger: roughly $400 million in long-term debt against $47 million in cash. That leverage leaves a thinner cushion if the integration slips or the Guatemala- and Peru-sourced fruit seasons disappoint.

The test that matters is the next two quarters. Does EBITDA actually step to the mid-$50 million range and hold, do the >$30 million synergies materialize as cash, and does the prepared-foods and blueberry business add margin rather than just revenue? Each is falsifiable, and none is proven yet. Mission has done something strategically sensible: it has diversified a volatile commodity business and added a real, higher-margin growth line. But the smartest deal in the world is a different question from a good stock at this price, and after a 30% run on a merger that is one quarter old, the market has largely paid for the thesis before the company has delivered the evidence. For now the disciplined reading is to let the Calavo integration prove itself into next year's EBITDA before treating the current multiple as cheap.